Humankind Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Buy |
4,349
+1,772
| +69% | +$718K | 0.43% | 33 |
|
|
2025
Q1 | $1.28M | Sell |
2,577
-49
| -2% | -$24.4K | 0.33% | 48 |
|
|
2024
Q4 | $1.37M | Buy |
2,626
+477
| +22% | +$248K | 0.35% | 40 |
|
|
2024
Q3 | $1.33M | Buy |
2,149
+83
| +4% | +$51.3K | 0.48% | 41 |
|
|
2024
Q2 | $1.14M | Buy |
2,066
+392
| +23% | +$217K | 0.3% | 49 |
|
|
2024
Q1 | $973K | Sell |
1,674
-150
| -8% | -$87.2K | 0.26% | 50 |
|
|
2023
Q4 | $968K | Buy |
1,824
+214
| +13% | +$114K | 0.29% | 49 |
|
|
2023
Q3 | $815K | Sell |
1,610
-20
| -1% | -$10.1K | 0.34% | 43 |
|
|
2023
Q2 | $850K | Buy |
1,630
+231
| +17% | +$121K | 0.33% | 43 |
|
|
2023
Q1 | $806K | Sell |
1,399
-57
| -4% | -$32.9K | 0.33% | 45 |
|
|
2022
Q4 | $802K | Buy |
1,456
+134
| +10% | +$73.8K | 0.35% | 46 |
|
|
2022
Q3 | $671K | Buy |
1,322
+144
| +12% | +$73.1K | 0.32% | 49 |
|
|
2022
Q2 | $640K | Buy |
1,178
+13
| +1% | +$7.06K | 0.31% | 52 |
|
|
2022
Q1 | $688K | Sell |
1,165
-348
| -23% | -$206K | 0.28% | 44 |
|
|
2021
Q4 | $1.01M | Buy |
1,513
+538
| +55% | +$359K | 1.27% | 24 |
|
|
2021
Q3 | $557K | Sell |
975
-77
| -7% | -$44K | 0.85% | 35 |
|
|
2021
Q2 | $531K | Buy |
1,052
+422
| +67% | +$213K | 0.95% | 38 |
|
|
2021
Q1 | $288K | Buy |
630
+189
| +43% | +$86.4K | 0.88% | 43 |
|
|
2020
Q4 | $205K | Buy |
+441
| New | +$205K | 0.21% | 22 |
|